Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Other Non Operating Income (2014 - 2026)

Scynexis' (SCYX) quarterly Other Non Operating Income came in at $335000.0 in Q2 2026, down 5.37% quarter-over-quarter from $354000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Other Non Operating Income (2014 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Other Non Operating Income for 9 consecutive years, with $335000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non Operating Income changed N/A year-over-year to $335000.0; the trailing twelve-month figure through Jun 2026 stood at $1.4 million (up 38.5% YoY), and the FY2025 full-year result was $750000.0, down 39.27% from the prior year.
  • Other Non Operating Income declined to $335000.0 in Q2 2026 per SCYX's latest filing, from $354000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.0 million in Q4 2024 and bottomed at -$406000.0 in Q1 2023.
  • Historically, Other Non Operating Income has averaged $338571.4 across 5 years, with a median of $189000.0 in 2022.
  • The widest YoY moves for Other Non Operating Income: up 533.33% in 2023, down 141.43% in 2023.
  • Over 5 years, Other Non Operating Income stood at $196000.0 in 2022, then surged by 375.51% to $932000.0 in 2023, then rose by 11.48% to $1.0 million in 2024, then declined by 27.82% to $750000.0 in 2025, then sank by 55.33% to $335000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $335000.0, $354000.0, and $750000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 335,000.00
Mar 31, 2026 354,000.00
Dec 31, 2025 750,000.00
Dec 31, 2024 1.04 Mn
Jun 30, 2024 28,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 932,000.00
Sep 30, 2023 182,000.00
Jun 30, 2023 42,000.00
Mar 31, 2023 -406,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 -42,000.00
Jun 30, 2022 182,000.00
Mar 31, 2022 980,000.00
Sep 30, 2021 1.40 Mn
Jun 30, 2021 462,000.00
Mar 31, 2021 -2.73 Mn
Dec 31, 2020 1.00 Mn
Sep 30, 2020 5.29 Mn
Jun 30, 2020 -806,000.00